Titre de série :	Topics in Current Chemistry
Titre :	Vol.252 : Contrast agents III: Radiopharmaceuticals - from diagnostics to therapeutics
Type de document :	texte imprimé
Auteurs :	Werner Krause, Éditeur scientifique
Editeur :	Berlin, Heidelberg : Springer
Année de publication :	2005
Collection :	Topics in Current Chemistry, ISSN 0340-1022 num. 252
Importance :	xii, 222 p.
Format :	24 cm
ISBN/ISSN/EAN :	978-3-540-22577-5
Langues :	Anglais (eng)
Note de contenu :	"* New organometallic technetium complexes for radiopharmaceutical imaging * Re and Tc complexes anchored by phosphines and scorpionates for radiopharmaceutical applications * Development of technetium-99m and rhenium-188 radiopharmaceuticals containing a terminal metal-nitrido multiple bond for diagnosis and therapy * HYNIC derivatives as bifunctional coupling Agents for 99mTc-labeling of small biomolecules * Monitoring multidrug resistance P-glycoprotein (MDR1 Pgp) drug transport activity with SPECT and PET radiopharmaceuticals * Radiopharmceuticals for PET imaging of somatostatin receptor positive tumor * Radiolabeled integrin avß3 antagonists as radiopharmaceuticals for tumor radiotherapy."
Cote :	EXCLU (SdL)
Num_Inv :	2724

Topics in Current Chemistry. Vol.252 : Contrast agents III: Radiopharmaceuticals - from diagnostics to therapeutics [texte imprimé] / Werner Krause, Éditeur scientifique . - Berlin, Heidelberg : Springer, 2005 . - xii, 222 p. ; 24 cm. - (Topics in Current Chemistry, ISSN 0340-1022; 252) .
ISBN : 978-3-540-22577-5
Langues : Anglais (eng)

Note de contenu :	"* New organometallic technetium complexes for radiopharmaceutical imaging * Re and Tc complexes anchored by phosphines and scorpionates for radiopharmaceutical applications * Development of technetium-99m and rhenium-188 radiopharmaceuticals containing a terminal metal-nitrido multiple bond for diagnosis and therapy * HYNIC derivatives as bifunctional coupling Agents for 99mTc-labeling of small biomolecules * Monitoring multidrug resistance P-glycoprotein (MDR1 Pgp) drug transport activity with SPECT and PET radiopharmaceuticals * Radiopharmceuticals for PET imaging of somatostatin receptor positive tumor * Radiolabeled integrin avß3 antagonists as radiopharmaceuticals for tumor radiotherapy."
Cote :	EXCLU (SdL)
Num_Inv :	2724